Immunohistochemical evaluation of chemically induced rhabdomyosarcomas in rats: Diagnostic utility of MyoD1

Toxicologic Pathology

Volumn 25, Issue 5, 1997, Pages 470-474

  Newsholme, Stephen J ^a   Zimmerman, Dawn M ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Desmin; Muscle tumors; Vimentin; actin

Indexed keywords

ALPHA ACTIN; DESMIN; FORMALDEHYDE; MONOCLONAL ANTIBODY; MUSCLE PROTEIN; MYOD1 PROTEIN; MYOSIN; NICKEL SUBSULFIDE; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SPINDLE CELL;

ANIMALIA;

EID: 0030874823     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339702500507     Document Type: Article

References (26)

1. Altmannsberger M, Weber K, Droste R, and Osborn M (1985). Desmin is a specific marker for rhabdomyosarcomas of human and rat origin. Am. J. Pathol. 118: 85-95.
2. Babai F, Skalli O, Schurch W, Seemayer TA, and Gabbiani G (1988). Chemically induced rhabdomoysarcomas in rats. Ultrastructural, immunohistochemical, biochemical features and expression of α-actin isoforms. Virchows Arch. B Cell Pathol. 55: 263-277.
3. Battifora H (1991). Assessment of antigen damage in immunohistochemistry. The vimentin internal control. Am. J. Clin. Pathol. 96: 669-671.
4. Boon ME, Schmidt U, Cramer-Knijnenburg GI, and Van Krieken JHJM (1992). Using Kryofix as alternative for formalin results in more optimal and standardized immunostaining of paraffin sections. Path. Res. Pract. 188: 832-835.
5. Borrione AC, Zanellato AMC, Saggin L, Mazzoli M, Azzarello G, and Sartore S (1988). Neonatal myosin heavy chains are not expressed in Ni-induced rat rhabdomyosarcoma. Differentiation 38: 49-59.
6. De Jong ASH, Van Vark M, Albus-Lutter CE, Van Raamsdonk W, and Voute PA (1984). Myosin and myoglobin as tumor markers in the diagnosis of rhabdomyosarcoma. Am. J. Surg. Pathol. 8: 521-528.
7. Dias P, Parham DM, and Shapiro DN (1992). Monoclonal antibodies to the myogenic regulatory protein MyoD1: Epitope mapping and diagnostic utility. Cancer Res. 52: 6431-6439.
8. Dias P, Parham DM, Shapiro DN, Webber BL, and Houghton PJ (1990). Myogenic regulatory protein (MyoD1) expression in childhood solid tumors. Am. J. Pathol. 137: 1283-1291.
9. Gilman JPW (1962). Metal carcinogenesis II. A study on the carcinogenic activity of cobalt, copper, iron and nickel compounds. Cancer Res. 22: 158-165.
10. Lazarides E and Balzer DR Jr (1978). Specificity of desmin to avian and mammalian muscle cells. Cell 14: 429-438.
11. Leader M, Collins M, Patel J, and Henry K (1987). Desmin: Its value as a marker of muscle derived tumours using a commercial antibody. Virchows Arch. A 411: 345-349.
12. Leong AS-Y and Gilham PN (1989). The effects of progressive formaldehyde fixation on the preservation of tissue antigens. Pathology 21: 266-268.
13. Miettinen M, Lehto VP, Badley RA, and Virtanen I (1982). Alveolar rhabdomyosarcoma: Demonstration of the muscle type of intermediate filament protein, desmin, as a diagnostic aid. Am. J. Pathol. 108: 246-251.
14. National Research Council (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.
15. Newsholme S and Zimmerman D (1996). Immunohistochemical expression of muscle tumors in rats. Vet. Pathol. 33: 589 (abstract).
16. Parham DM, Dias P, Bertorini T, von Wronski MA, Horner L, and Houghton P (1994). Immunohistochemical analysis of the distribution of MyoD1 in muscle biopsies of primary myopathies and neurigenic atrophy. Acta Neuropathol. 87: 605-611.
17. Rosai J, Dias P, Parham DM, Shapiro DN, and Houghton P (1991). MyoD1 protein expression in alveolar soft part sarcoma as confirmatory evidence of its skeletal muscle nature. Am. J. Surg. Pathol. 15: 974-981.
18. Sano N, Shibata M, Izumi K, and Otsuka H (1988). Histopathological and immunohistochemical studies on nickel sulfide-induced tumors in F344 rats. Jpn. J. Cancer Res. (Gann) 79: 212-221.
19. Schurch W, Skalli O, Seemayer TA, and Gabbiani G (1987). Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. I. Smooth muscle tumors. Am. J. Pathol. 128: 91-103.
20. Shi S-R, Key ME, and Kalra K (1991). Antigen retrievel in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem. 39: 741-748.
21. Skalli O, Ropraz P, Trzeciak A, Benzonana G, and Gillessen D (1986). A monoclonal antibody against α smooth muscle actin: A new probe for smooth muscle differentiation. J. Cell Biol. 103: 2787-2796.
22. Takahashi K, Maita Y, Shirasu Y, Taniguchi H, and Yoshikawa Y (1988). Anti-rat myoglobin antisera in the immunocytochemical diagnosis of rhabdomyosarcomas of rats. Vet. Pathol. 25: 337-342.
23. Tapscott SJ, Davis RL, and Thayer MJ (1988). MyoDl: A nuclear phosphoprotein requiring a myc homology region to convert fibroblasts to myoblasts. Science 242: 405-411.
24. Weis J (1994). Jun, Fos, MyoD1, and Myogenin proteins are increased in skeletal muscle fiber nuclei after denervation. Acta Neuropathol. 87: 63-70.
25. Wesch WA, Fletcher CDM, Dias P, Houghton PJ, and Parham DM (1995). Immunohistochemistry of MyoD1 in adult pleomorphic soft tissue sarcomas. Am. J. Surg. Pathol. 19: 261-269.
26. Yamashiro S, Gilman GPW, Hulland TJ, and Abandowitz HM (1980). Nickel sulfide-induced rhabdomyosarcomata in rats. Acta Pathol. Jpn. 30: 9-22.